Jian Xu

Jian Xu

Auto-generated profile, based on publicly available information

Jian Xu

Department of Medicine, Washington University School of Medicine, St. Louis, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2023 in JCI Insight
Verified
Journal Article
Open access
PDF file
AHAmjad Horani
Amjad Horani
DGDeepesh Kumar Gupta
Deepesh Kumar Gupta
JXJian Xu
Jian Xu
HXHuihui Xu
Huihui Xu
LPLis del Carmen Puga-Molina
Lis del Carmen Puga-Molina
SBSteven Brody
Steven Brody
DNAAF5 is a dynein motor assembly factor associated with the autosomal heterogenic recessive condition of motile cilia, primary ciliary dyskinesia (PCD). The effects of allele heterozygosity on motile cilia function are unknown. We used CRISPR-Cas9 genome editing in mice to recreate a human missense variant identified in patients with mild PCD and a second, frameshift-null deletion in Dnaaf5 . Litters with Dnaaf5 heteroallelic variants showed distinct missense and null gene dosage effects. Homozygosity for the null Dnaaf5 alleles was embryonic lethal. Compound heterozygous animals with the missense and null alleles showed severe disease manifesting as hydrocephalus and early lethality. However, animals homozygous for the missense mutation had improved survival, with partially preserved cilia function and motor assembly observed by ultrastructure analysis. Notably, the same variant alleles exhibited divergent cilia function across different multiciliated tissues. Proteomic analysis of isolated airway cilia from mutant mice revealed reduction in some axonemal regulatory and structural proteins not previously reported in DNAAF5 variants. Transcriptional analysis of mouse and human mutant cells showed increased expression of genes coding for axonemal proteins. These findings suggest allele-specific and tissue-specific molecular requirements for cilia motor assembly that may affect disease phenotypes and clinical trajectory in motile ciliopathies.

29 January 2025 in Science Translational Medicine
Verified
Journal Article
Closed access
SBSteven Brody
Steven Brody
JPJiehong Pan
Jiehong Pan
THTao Huang
Tao Huang
JXJian Xu
Jian Xu
HXHuihui Xu
Huihui Xu
SDSusan K. Dutcher
Susan K. Dutcher
Primary ciliary dyskinesia is a rare monogenic syndrome that is associated with chronic respiratory disease, infertility, and laterality defects. Although more than 50 genes causative of primary ciliary dyskinesia have been identified, variants in the genes encoding coiled-coil domain-containing 39 (CCDC39) and CCDC40 in particular cause severe disease that is not explained by loss of ciliary motility alone. Here, we sought to understand the consequences of these variants on cellular functions beyond impaired motility. We used human cells with pathogenic variants in CCDC39 and CCDC40 , Chlamydomonas reinhardtii genetics, cryo–electron microscopy, and proteomics to define perturbations in ciliary assembly and cilia stability, as well as multiple motility-independent pathways. Analysis of proteomics of cilia from patient cells identified that the absence of the axonemal CCDC39/CCDC40 heterodimer resulted in the loss of a network of more than 90 ciliary structural proteins, including 14 that were defined as ciliary address recognition proteins, which provide docking for the missing structures. The absence of the network impaired microtubule architecture, activated cell quality control pathways, switched multiciliated cell fate to mucus-producing cells and resulted in a defective periciliary barrier. In CCDC39 variant cells, these phenotypes were reversed through expression of a normal CCDC39 transgene. These findings indicate that the CCDC39/CCDC40 heterodimer functions as a scaffold to support the assembly of an extensive network of ciliary proteins, whose loss results in both motility-dependent and motility-independent phenotypes that may explain the severity of disease. Gene therapy might be a potential treatment option to be explored in future studies.

27 September 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
MPMaritza Puray-Chavez
Maritza Puray-Chavez
JEJenna E. Eschbach
Jenna E. Eschbach
MXMing Xia
Ming Xia
KLKyle M. LaPak
Kyle M. LaPak
QZQianzi Zhou
Qianzi Zhou
SKSebla B. Kutluay
Sebla B. Kutluay
Host factors that define the cellular tropism of SARS-CoV-2 beyond the cognate ACE2 receptor are poorly defined. Here we report that SARS-CoV-2 replication is restricted at a post-entry step in a number of ACE2-positive airway-derived cell lines due to tonic activation of the cGAS-STING pathway mediated by mitochondrial DNA leakage and naturally occurring cGAS and STING variants. Genetic and pharmacological inhibition of the cGAS-STING and type I/III IFN pathways as well as ACE2 overexpression overcome these blocks. SARS-CoV-2 replication in STING knockout cell lines and primary airway cultures induces ISG expression but only in uninfected bystander cells, demonstrating efficient antagonism of the type I/III IFN-pathway in productively infected cells. Pharmacological inhibition of STING in primary airway cells enhances SARS-CoV-2 replication and reduces virus-induced innate immune activation. Together, our study highlights that tonic activation of the cGAS-STING and IFN pathways can impact SARS-CoV-2 cellular tropism in a manner dependent on ACE2 expression levels.

25 March 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
PKParismita Kalita
Parismita Kalita
OKOam Khatavkar
Oam Khatavkar
GUGrace Uwase
Grace Uwase
YKYulia Korshunova
Yulia Korshunova
YHYuying Hu
Yuying Hu
DLDaisy Leung
Daisy Leung
The Mediator complex facilitates interactions between transcription factors and RNA polymerase II, a process that is required for host gene transcription, including in response to viral infections. Among the many subunits in the Mediator complex, the MED25 subunit has been shown to be a target for viral activators during infection. Here we provide the molecular basis for the interaction between human respiratory syncytial virus (hRSV) nonstructural 1 protein (NS1) and the activator interaction domain (ACID) of MED25. The X-ray crystal structure of the complex revealed that NS1 straddles and binds two faces of MED25 ACID. This interaction is distinct from previously known viral activators. Importantly, our data support the conformational flexibility of viral transcriptional regulators. Furthermore, ChIP-seq and RNA-seq analysis identified the ATF3 transcription factor and a role for NS1/Mediator/ATF3 interaction in host gene regulation in hRSV infections. Our findings provide a molecular basis for hRSV NS1-based regulation of host gene transcription and reveal how viruses exploit the conformational heterogeneity at fuzzy transcription activator interfaces.

11 June 2018 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
ZLZhongqiang Li
Zhongqiang Li
SYShaomian Yao
Shaomian Yao
JXJian Xu
Jian Xu
YWYe Wu
Ye Wu
LCLi Chunhong
Li Chunhong
ZHZiying He
Ziying He